These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36738836)

  • 1. Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus.
    Zhu J; Han J; Liu L; Liu Y; Xu W; Li X; Yang L; Gu Y; Tang W; Shi Y; Ye S; Hua F; Xiang G; Liu M; Sun Z; Su Q; Li X; Li Y; Li Y; Li H; Li Y; Yang T; Yang J; Shi L; Yu X; Chen L; Shao J; Liang J; Han X; Xue Y; Ma J; Zhu D; Mu Y;
    Diabetes Res Clin Pract; 2023 Mar; 197():110568. PubMed ID: 36738836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
    Tanday N; Irwin N; Flatt PR; Moffett RC
    Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
    Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
    Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice.
    Takasu T; Takakura S
    Biol Pharm Bull; 2018; 41(5):761-769. PubMed ID: 29709913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE; Salsali A
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: a cross-sectional study from China.
    Yuan X; Ding S; Zhou L; Wen S; Du A; Diao J
    Ann Palliat Med; 2021 Jul; 10(7):8169-8179. PubMed ID: 34353101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
    Chen L; Klein T; Leung PS
    Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B
    Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence.
    van Genugten RE; van Raalte DH; Diamant M
    Diabetes Obes Metab; 2012 Feb; 14(2):101-11. PubMed ID: 21752172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
    Triolo TM; Bellin MD
    Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Pericytes in Glucose Homeostasis and Diabetes.
    Landsman L
    Adv Exp Med Biol; 2019; 1122():27-40. PubMed ID: 30937861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model.
    Villaça CBP; de Paula CC; de Oliveira CC; Vilas-Boas EA; Dos Santos-Silva JC; de Oliveira SF; Abdulkader F; Ferreira SM; Ortis F
    Exp Physiol; 2021 Jul; 106(7):1482-1497. PubMed ID: 33913203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.